Some believe TEVA will have interest in OWCP again in the near future.
OWCP has news out today talking about many big things that really should make them an even more serious Medical Cannabis biotech.
With a 52-week High of $3.23 after they were found to be included on the "ArgoSphere ETF" (which may launch in May), I see NO REASON they won't set a new 52-week high soon considering today's PR and the near-future clinical trial completion. That would be gains of over 200% in the short term and definitely more and more in the long term.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.